Annual CFI
-$10.99 M
-$145.00 K-1.34%
December 31, 2023
Summary
- As of February 7, 2025, AUTL annual cash flow from investing activities is -$10.99 million, with the most recent change of -$145.00 thousand (-1.34%) on December 31, 2023.
- During the last 3 years, AUTL annual CFI has risen by +$3.69 million (+25.17%).
- AUTL annual CFI is now -492.24% below its all-time high of -$1.85 million, reached on September 30, 2016.
Performance
AUTL Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$9.59 M
-$8.75 M-1040.19%
September 30, 2024
Summary
- As of February 7, 2025, AUTL quarterly cash flow from investing activities is -$9.59 million, with the most recent change of -$8.75 million (-1040.19%) on September 30, 2024.
- Over the past year, AUTL quarterly CFI has dropped by -$9.06 million (-1699.06%).
- AUTL quarterly CFI is now -1699.06% below its all-time high of -$533.00 thousand, reached on March 31, 2024.
Performance
AUTL Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$12.44 M
-$8.09 M-186.04%
September 30, 2024
Summary
- As of February 7, 2025, AUTL TTM cash flow from investing activities is -$12.44 million, with the most recent change of -$8.09 million (-186.04%) on September 30, 2024.
- Over the past year, AUTL TTM CFI has dropped by -$4.54 million (-57.53%).
- AUTL TTM CFI is now -186.04% below its all-time high of -$4.35 million, reached on June 30, 2024.
Performance
AUTL TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
AUTL Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.3% | -1699.1% | -57.5% |
| 3 y3 years | +25.2% | -118.5% | +19.4% |
| 5 y5 years | -148.4% | -118.5% | +19.4% |
AUTL Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -24.0% | at low | -1699.1% | at low | -186.0% | +19.4% |
| 5 y | 5-year | -24.0% | +41.1% | -1699.1% | at low | -186.0% | +33.4% |
| alltime | all time | -492.2% | +41.1% | -1699.1% | at low | -186.0% | +33.4% |
Autolus Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$9.59 M(+1040.2%) | -$12.44 M(+186.0%) |
| Jun 2024 | - | -$841.00 K(+57.8%) | -$4.35 M(-44.9%) |
| Mar 2024 | - | -$533.00 K(-63.9%) | -$7.90 M(-28.1%) |
| Dec 2023 | -$10.99 M(+1.3%) | -$1.48 M(-1.4%) | -$10.99 M(+8.3%) |
| Sep 2023 | - | -$1.50 M(-65.9%) | -$10.14 M(-34.3%) |
| Jun 2023 | - | -$4.39 M(+21.2%) | -$15.44 M(+12.8%) |
| Mar 2023 | - | -$3.62 M(+472.2%) | -$13.69 M(+26.3%) |
| Dec 2022 | -$10.84 M(+22.4%) | -$633.00 K(-90.7%) | -$10.84 M(-8.1%) |
| Sep 2022 | - | -$6.80 M(+157.5%) | -$11.79 M(+33.1%) |
| Jun 2022 | - | -$2.64 M(+242.4%) | -$8.86 M(+14.6%) |
| Mar 2022 | - | -$771.00 K(-51.4%) | -$7.73 M(-12.7%) |
| Dec 2021 | -$8.86 M | -$1.58 M(-58.9%) | -$8.86 M(-30.5%) |
| Sep 2021 | - | -$3.86 M(+155.5%) | -$12.74 M(-1.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$1.51 M(-20.5%) | -$12.93 M(-7.3%) |
| Mar 2021 | - | -$1.90 M(-65.3%) | -$13.94 M(-5.0%) |
| Dec 2020 | -$14.68 M(-21.4%) | -$5.47 M(+35.1%) | -$14.68 M(+32.0%) |
| Sep 2020 | - | -$4.05 M(+60.5%) | -$11.12 M(+2.5%) |
| Jun 2020 | - | -$2.52 M(-4.3%) | -$10.86 M(-22.3%) |
| Mar 2020 | - | -$2.64 M(+37.8%) | -$13.98 M(-25.1%) |
| Dec 2019 | -$18.67 M(+322.2%) | -$1.91 M(-49.4%) | -$18.67 M(+11.4%) |
| Sep 2019 | - | -$3.78 M(-33.0%) | -$16.75 M(+29.1%) |
| Jun 2019 | - | -$5.64 M(-23.0%) | -$12.97 M(+77.0%) |
| Mar 2019 | - | -$7.33 M | -$7.33 M |
| Dec 2018 | -$4.42 M(-53.6%) | - | - |
| Sep 2018 | -$9.53 M(+231.4%) | - | - |
| Sep 2017 | -$2.88 M(+55.0%) | - | - |
| Sep 2016 | -$1.85 M | - | - |
FAQ
- What is Autolus Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Autolus Therapeutics?
- What is Autolus Therapeutics annual CFI year-on-year change?
- What is Autolus Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Autolus Therapeutics?
- What is Autolus Therapeutics quarterly CFI year-on-year change?
- What is Autolus Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Autolus Therapeutics?
- What is Autolus Therapeutics TTM CFI year-on-year change?
What is Autolus Therapeutics annual cash flow from investing activities?
The current annual CFI of AUTL is -$10.99 M
What is the all time high annual CFI for Autolus Therapeutics?
Autolus Therapeutics all-time high annual cash flow from investing activities is -$1.85 M
What is Autolus Therapeutics annual CFI year-on-year change?
Over the past year, AUTL annual cash flow from investing activities has changed by -$145.00 K (-1.34%)
What is Autolus Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of AUTL is -$9.59 M
What is the all time high quarterly CFI for Autolus Therapeutics?
Autolus Therapeutics all-time high quarterly cash flow from investing activities is -$533.00 K
What is Autolus Therapeutics quarterly CFI year-on-year change?
Over the past year, AUTL quarterly cash flow from investing activities has changed by -$9.06 M (-1699.06%)
What is Autolus Therapeutics TTM cash flow from investing activities?
The current TTM CFI of AUTL is -$12.44 M
What is the all time high TTM CFI for Autolus Therapeutics?
Autolus Therapeutics all-time high TTM cash flow from investing activities is -$4.35 M
What is Autolus Therapeutics TTM CFI year-on-year change?
Over the past year, AUTL TTM cash flow from investing activities has changed by -$4.54 M (-57.53%)